Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22824,179,1.16 [0.84-1.60],0.374187058308132
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23862,191,1.71 [1.31-2.22],6.388445081316219e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23617,1423,1.40 [1.26-1.56],2.9436078556617606e-10
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23876,380,1.36 [1.10-1.67],0.0036588607688536
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23181,3493,1.35 [1.26-1.45],6.8594165557303385e-18
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23138,3508,1.43 [1.33-1.53],8.282471747913724e-25
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23660,1053,1.28 [1.12-1.45],0.0001647304041718
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23797,81,2.00 [1.38-2.91],0.0002731590582069
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21648,1127,1.50 [1.34-1.69],9.689071806224536e-12
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20884,1248,1.68 [1.52-1.87],3.532223956374536e-22
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20606,253,1.65 [1.30-2.10],4.5343280240011165e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16800,2285,1.40 [1.28-1.52],8.071229966290124e-15
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20536,406,1.43 [1.17-1.75],0.0005171857696768
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23866,1259,1.30 [1.16-1.46],7.348288379533875e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,23968,472,1.33 [1.11-1.60],0.0025382374705925
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23095,901,1.43 [1.26-1.63],8.14300977336186e-08
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23889,1244,1.44 [1.29-1.61],2.2579735781953318e-10
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22800,193,1.71 [1.32-2.22],5.7822308175233965e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24007,53,0.88 [0.47-1.66],0.6938682923177769
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23731,1086,1.41 [1.25-1.59],2.5360164025035385e-08
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23788,72,1.51 [0.95-2.39],0.0805542864770245
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23943,119,1.63 [1.17-2.28],0.0039555911624921
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23925,101,1.53 [1.05-2.23],0.0254904294584026
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22692,498,1.61 [1.36-1.90],1.607172435451933e-08
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22482,288,1.20 [0.94-1.55],0.1495790842265105
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22696,89,1.14 [0.72-1.79],0.572023824682352
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23988,70,2.01 [1.34-3.02],0.0007446185306248
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23953,144,1.11 [0.78-1.59],0.5655861909669103
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,23861,52,0.98 [0.53-1.84],0.9616420934610924
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23860,51,1.37 [0.79-2.40],0.2648560139008648
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23689,347,1.00 [0.78-1.27],0.9767441698503644
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23935,45,1.14 [0.60-2.17],0.6943864601996745
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23901,55,1.05 [0.58-1.90],0.8743963226433514
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23959,131,0.86 [0.57-1.29],0.4625314635470298
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23632,1653,1.06 [0.95-1.18],0.2972647883984291
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of meninges,24007,32,0.77 [0.33-1.77],0.5343111414375434
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23943,66,1.26 [0.75-2.11],0.3811847164513351
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23991,78,1.22 [0.76-1.95],0.4041816855353671
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23982,445,1.15 [0.94-1.41],0.1747942355953798
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,23977,340,0.98 [0.77-1.25],0.8909998670206344
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23876,83,0.95 [0.58-1.56],0.8517670988431076
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23975,278,1.38 [1.09-1.75],0.0072144803284853
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23935,427,1.05 [0.85-1.30],0.6659691346218233
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23883,732,1.14 [0.97-1.33],0.1112938690047342
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23964,565,1.01 [0.84-1.22],0.9187778623491784
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18653,71,1.26 [0.76-2.07],0.365590473018387
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18654,72,1.17 [0.70-1.94],0.5472585808328772
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23975,101,1.26 [0.83-1.89],0.2780067392965427
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",23975,98,1.28 [0.85-1.94],0.2340035820419319
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,15981,344,1.18 [0.94-1.49],0.1629026506629112
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lymphoid leukaemia,18647,65,1.12 [0.65-1.92],0.6930629348008659
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18783,201,1.16 [0.86-1.58],0.3282285841490376
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18876,294,1.13 [0.87-1.46],0.3569777194675076
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18673,91,3.15 [2.35-4.24],2.5221349719984007e-14
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18727,145,0.97 [0.66-1.42],0.8754870015365085
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18721,139,1.23 [0.86-1.75],0.2543565479357489
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18665,83,1.09 [0.67-1.78],0.7337317866967852
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",20000,1418,0.97 [0.86-1.10],0.6444248481530255
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18728,146,1.20 [0.84-1.71],0.3208499298313075
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18689,107,1.11 [0.73-1.69],0.620965410009566
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18712,130,1.21 [0.82-1.77],0.3323752304571325
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,23878,170,1.15 [0.83-1.59],0.4127371455275085
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,23974,94,1.54 [1.04-2.28],0.0295901327290941
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanoma in situ,18615,74,0.72 [0.41-1.28],0.2620464713518191
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18683,101,1.19 [0.78-1.82],0.4276043788707665
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18751,169,1.10 [0.79-1.55],0.57180444169368
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18801,219,0.86 [0.63-1.19],0.3651084544223353
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18685,103,1.11 [0.72-1.71],0.6403977820687714
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23872,140,0.76 [0.51-1.14],0.1874285868985457
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19798,1216,1.05 [0.92-1.19],0.4678657692581371
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19876,1294,1.08 [0.95-1.22],0.2274315916206626
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23729,309,1.17 [0.92-1.49],0.2089114964738538
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22262,118,1.97 [1.44-2.69],2.3300947474343005e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23493,73,2.00 [1.36-2.93],0.0003902658868732
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23441,2793,1.40 [1.30-1.51],2.2838942973699082e-18
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22725,62,1.90 [1.22-2.95],0.0044327792772144
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23580,53,1.15 [0.64-2.07],0.6417073650204725
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23625,1481,1.44 [1.30-1.60],1.863652004960889e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23623,1479,1.45 [1.31-1.60],1.4991444262554289e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22248,104,1.45 [0.98-2.14],0.0638553026610643
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23765,1102,1.49 [1.33-1.68],1.6104057141569203e-11
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23631,104,1.72 [1.22-2.45],0.00223904355433
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23497,77,1.47 [0.95-2.27],0.0829628668161469
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23481,61,1.35 [0.80-2.26],0.2597107136421645
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23842,315,1.76 [1.44-2.15],2.9834629039779175e-08
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23910,48,1.11 [0.59-2.09],0.7427558772643307
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23783,256,1.86 [1.50-2.31],1.964423358056156e-08
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22741,78,1.19 [0.74-1.92],0.4632049305205127
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17709,380,1.68 [1.39-2.03],9.288826074846797e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21954,165,1.41 [1.02-1.94],0.038033694014163
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21981,192,2.26 [1.70-3.01],1.8910675227387373e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17387,58,1.78 [1.11-2.86],0.0174441630791645
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22617,64,0.78 [0.43-1.40],0.4055056141768107
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21840,227,1.12 [0.84-1.50],0.424443774271544
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23503,622,1.34 [1.13-1.58],0.0005465730685333
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23122,241,1.25 [0.95-1.64],0.1147006901469379
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23050,169,0.79 [0.55-1.14],0.2125217837483491
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23699,1146,1.05 [0.92-1.19],0.4915495499883361
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20543,1103,1.10 [0.97-1.26],0.149935434742811
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17404,75,1.55 [1.00-2.41],0.0481687014142537
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23123,39,1.18 [0.60-2.33],0.6305762462159489
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17604,275,1.48 [1.17-1.88],0.001041981254974
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17402,73,2.30 [1.61-3.30],4.809884723218044e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21230,3901,1.05 [0.98-1.13],0.1979033525195062
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17517,188,1.61 [1.23-2.13],0.0006719205175468
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17902,573,1.61 [1.37-1.88],3.493838770196948e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23947,280,1.22 [0.96-1.57],0.1104782946919601
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23758,91,1.19 [0.77-1.83],0.4308551709778817
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17485,156,1.78 [1.33-2.38],0.0001055386271521
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17395,66,1.87 [1.23-2.85],0.0033250777108457
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23829,745,1.14 [0.98-1.34],0.0880593608645928
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17636,307,1.90 [1.56-2.32],1.3233434723388752e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17714,385,1.81 [1.51-2.16],1.171192459915478e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18063,734,1.24 [1.06-1.44],0.0070159664345584
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17475,146,1.24 [0.88-1.75],0.220812446919506
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23751,84,1.18 [0.75-1.86],0.4633429994707778
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17899,570,1.37 [1.15-1.62],0.0002974422263791
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17724,395,1.67 [1.38-2.01],9.026213346123957e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21683,70,1.82 [1.18-2.80],0.0064645071796618
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22557,5228,1.13 [1.06-1.20],9.259773204970504e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23104,20,0.54 [0.17-1.66],0.2830468048399245
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23106,22,1.55 [0.67-3.55],0.3041730524447827
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23832,1797,0.99 [0.89-1.10],0.8588947135004539
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23829,1793,0.99 [0.89-1.09],0.7855531083803629
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23106,22,0.99 [0.38-2.57],0.9846555749636756
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23734,803,1.10 [0.94-1.28],0.2184156939358686
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18957,1628,1.49 [1.36-1.64],2.2763997001932773e-16
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23996,268,1.91 [1.55-2.36],1.6093824605344731e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22990,109,2.13 [1.55-2.92],2.784764282465258e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23006,75,1.20 [0.73-1.96],0.4717442279931004
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23013,82,1.12 [0.69-1.79],0.6517527160876347
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17395,66,1.05 [0.61-1.81],0.8628384248105383
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21193,167,2.29 [1.79-2.94],6.285033468092834e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2530,124,2.03 [1.54-2.69],5.251776008651849e-07
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2692,319,1.37 [1.11-1.69],0.0036728486978738
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21127,101,3.33 [2.56-4.35],6.096115194515075e-19
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2486,82,2.11 [1.49-3.00],2.802063874189226e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23215,2189,1.56 [1.44-1.70],6.975345754955944e-26
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23243,362,1.25 [1.00-1.56],0.0485324841501958
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21855,242,1.58 [1.23-2.02],0.0003554971484357
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18135,806,1.44 [1.26-1.66],2.240256461082599e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23884,253,1.21 [0.93-1.57],0.1574159124238065
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22771,273,0.74 [0.55-1.00],0.0517746720390276
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,21064,1504,1.09 [0.98-1.22],0.1173546655522225
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22882,384,0.96 [0.76-1.21],0.7115201951644274
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22583,85,2.08 [1.44-3.01],9.172677049460363e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22747,249,1.89 [1.51-2.36],2.2278696838187163e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14070,2340,1.49 [1.37-1.62],2.344137534323605e-21
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,AV-block,19302,630,1.45 [1.24-1.70],3.569787584992351e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23931,542,1.15 [0.96-1.38],0.1400133209774678
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11981,251,1.90 [1.51-2.39],3.2304077593746926e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18876,204,1.78 [1.39-2.30],7.198103744521048e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18784,112,2.10 [1.54-2.88],3.6088701454440806e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24008,69,1.67 [1.07-2.60],0.0230206520203368
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,20047,1375,1.54 [1.39-1.71],3.367360548256807e-16
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22185,2649,1.18 [1.09-1.28],6.554937524562665e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20219,7823,1.16 [1.10-1.22],3.3037838394069794e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22772,276,1.25 [0.97-1.61],0.0798570024893309
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Endocarditis,18759,87,1.94 [1.35-2.78],0.0003691326998774
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23695,1343,1.78 [1.62-1.97],3.8494170337766285e-31
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,21423,6811,1.18 [1.12-1.24],1.647018283636798e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21447,6835,1.17 [1.11-1.23],3.808000616279006e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23776,113,4.74 [3.92-5.73],2.832612841414763e-58
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14798,186,2.60 [2.09-3.23],8.268014599457066e-18
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14783,171,1.99 [1.53-2.59],2.3267795906629642e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,23859,1246,1.44 [1.29-1.61],1.4560392585171428e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22926,116,1.41 [0.97-2.05],0.0688687101887376
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22324,2764,1.15 [1.06-1.24],0.001027263194406
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23572,659,1.41 [1.21-1.65],1.3591077749105837e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,19093,421,1.80 [1.51-2.14],3.8271786518876056e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23272,1071,1.16 [1.02-1.32],0.028364317291994
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20490,930,1.23 [1.07-1.41],0.0039669480645673
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23845,225,1.00 [0.74-1.34],0.9893733553747928
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23955,375,1.32 [1.07-1.62],0.0106017503120225
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22566,70,5.00 [3.93-6.36],4.2629230461475956e-39
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,22596,98,1.13 [0.73-1.76],0.5887225459854256
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,19160,488,1.34 [1.12-1.62],0.0018019442237606
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22633,135,1.76 [1.28-2.41],0.0004657352037874
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22780,282,1.55 [1.24-1.95],0.0001593416650038
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18870,198,1.68 [1.30-2.18],9.549886575190884e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22595,99,2.04 [1.45-2.86],4.096006293367341e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22548,52,2.09 [1.31-3.34],0.0019368850220503
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22404,91,1.40 [0.92-2.13],0.1142694336291169
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22602,106,1.61 [1.12-2.31],0.0099077709929127
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19933,1261,1.67 [1.51-1.86],1.2135421261603624e-22
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22679,66,4.31 [3.33-5.57],1.0000408722976114e-28
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23076,578,1.53 [1.30-1.79],2.247152415108625e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23358,367,2.07 [1.75-2.46],5.12862090402912e-17
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22987,674,1.24 [1.06-1.46],0.0086790826545776
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12117,387,1.93 [1.61-2.32],1.6023451059874842e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22985,536,1.80 [1.54-2.10],1.09786143703607e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22853,357,1.23 [0.99-1.54],0.0669918837215686
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23494,503,1.17 [0.97-1.42],0.0982782006056058
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23945,719,1.64 [1.43-1.88],2.2931394574117032e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19148,476,1.61 [1.35-1.91],9.27360349544238e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23356,365,2.07 [1.74-2.46],8.606392441990123e-17
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22537,224,1.57 [1.21-2.02],0.0005575399545768
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23556,746,1.40 [1.21-1.62],5.897438017328627e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23540,775,1.42 [1.23-1.64],1.3302801805191091e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22903,47,1.70 [1.00-2.89],0.0491570801920093
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22612,115,1.20 [0.81-1.79],0.3646326651061884
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23163,250,1.29 [0.99-1.67],0.05980975599571
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22519,318,0.99 [0.77-1.27],0.9302955810271336
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22879,383,1.49 [1.22-1.82],8.727604079345926e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22515,75,1.13 [0.69-1.86],0.6305305653069283
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23769,788,1.15 [0.99-1.34],0.0716598351489225
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23808,499,1.80 [1.53-2.11],6.676944060022615e-13
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20636,972,1.10 [0.95-1.26],0.2039061273650802
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,23312,3648,1.22 [1.13-1.30],6.495326833806724e-08
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23745,589,1.69 [1.45-1.97],1.3620688163065211e-11
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20846,1182,1.10 [0.96-1.25],0.1606553391936855
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19749,85,1.04 [0.64-1.70],0.8735756542280333
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,23360,1541,1.33 [1.20-1.49],1.870543795567255e-07
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21543,1879,1.39 [1.26-1.54],6.840326417751277e-11
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Vascular dementia,23496,152,1.56 [1.15-2.13],0.0046079748734919
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,24006,297,1.19 [0.93-1.53],0.1635720631570278
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15952,58,1.40 [0.81-2.41],0.2285198339727318
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Bell's palsy,22620,78,1.75 [1.16-2.64],0.0078430665149219
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22888,346,1.04 [0.82-1.31],0.7488110765947955
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,23599,237,1.46 [1.13-1.88],0.0039445617319998
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23920,364,1.28 [1.04-1.59],0.0218836957754557
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23496,59,0.51 [0.26-0.98],0.0446376780225699
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23987,73,1.45 [0.93-2.27],0.1033142880841528
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23454,92,1.28 [0.83-1.98],0.2622101402536795
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,22373,289,1.13 [0.88-1.46],0.3309470867778145
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23463,1379,1.05 [0.94-1.18],0.3844864972141502
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23971,690,1.00 [0.84-1.19],0.9928538430490506
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23453,2222,1.22 [1.11-1.33],1.404565976225064e-05
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23614,60,2.07 [1.35-3.19],0.0009312243627978
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23836,280,1.38 [1.09-1.75],0.0081768768762097
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,23417,55,1.54 [0.92-2.59],0.0995900841190144
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23989,60,1.13 [0.65-1.97],0.6610319058165637
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22563,21,0.90 [0.33-2.45],0.830567046839763
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22636,94,1.18 [0.76-1.81],0.4640724344730791
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Memory loss,23333,120,1.22 [0.84-1.79],0.2959200767008849
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,22284,200,0.70 [0.49-0.99],0.0418196725674001
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23983,180,0.61 [0.42-0.88],0.0092262798527906
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,16060,153,0.98 [0.68-1.43],0.929151351423568
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23895,65,0.60 [0.32-1.11],0.1049312076687257
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23530,988,1.17 [1.02-1.34],0.0221053965925586
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,22675,3702,1.17 [1.09-1.25],1.2090562311366887e-05
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23679,242,1.22 [0.93-1.60],0.1525578049179738
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22937,395,1.21 [0.98-1.50],0.0715353113580337
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23914,360,1.90 [1.59-2.27],2.3685651732736905e-12
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18817,624,1.16 [0.97-1.38],0.0971611280699311
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23443,81,0.99 [0.60-1.62],0.9532811634435608
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23518,156,1.25 [0.90-1.74],0.1754129144868115
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23422,141,1.06 [0.73-1.53],0.7570308030096382
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22639,97,1.60 [1.09-2.34],0.0168421310811536
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,22123,39,0.68 [0.31-1.47],0.3252019042714797
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23888,526,1.25 [1.05-1.50],0.0144204442276574
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22794,710,1.01 [0.86-1.19],0.869288293317642
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,23985,541,0.96 [0.80-1.17],0.718241640001154
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23388,26,0.66 [0.25-1.74],0.3967421966025247
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,24007,51,1.05 [0.56-1.96],0.871566724849495
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23700,640,1.03 [0.87-1.22],0.7615756923997627
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,59,2.04 [1.34-3.10],0.0008672208968627
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23989,179,1.05 [0.76-1.46],0.7514565632750783
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22577,35,0.82 [0.37-1.83],0.6337840458739499
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24006,300,1.20 [0.94-1.54],0.1413843176363245
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23465,148,1.58 [1.16-2.16],0.0039676009147508
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23453,86,1.04 [0.64-1.67],0.8842740310087985
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23658,303,1.05 [0.81-1.36],0.7181726312972809
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23806,293,1.72 [1.39-2.13],4.898570662354981e-07
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23125,44,1.40 [0.78-2.51],0.2537024522699316
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23143,62,1.02 [0.58-1.80],0.9532781319730154
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23913,43,0.83 [0.41-1.68],0.6017588027252379
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23772,125,1.11 [0.75-1.64],0.609270083902508
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2490,84,2.08 [1.47-2.94],3.496203359729398e-05
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3030,132,2.01 [1.56-2.59],7.684077091044173e-08
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23463,96,0.84 [0.52-1.35],0.4767601524162198
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23754,1002,1.27 [1.12-1.45],0.0002939581516234
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23700,619,1.03 [0.87-1.23],0.7145474586630043
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23227,146,1.00 [0.69-1.45],0.993208541792526
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23931,576,1.09 [0.91-1.31],0.3638041739667295
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24004,66,1.11 [0.65-1.90],0.6977573730384117
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23862,507,1.02 [0.84-1.25],0.8321386654199222
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23968,321,1.14 [0.89-1.45],0.2945808658529089
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23917,149,0.76 [0.52-1.13],0.1823043434389576
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23160,79,1.15 [0.71-1.86],0.5639438164552375
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23166,85,0.69 [0.40-1.17],0.1657923238110666
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23125,44,1.18 [0.62-2.24],0.6170596840957469
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23911,681,1.10 [0.93-1.30],0.2559095347956416
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23412,182,1.01 [0.73-1.41],0.9408385926592946
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23385,30,1.09 [0.50-2.41],0.825637065446715
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23744,97,1.49 [1.01-2.22],0.0470335031844216
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23877,230,1.07 [0.80-1.44],0.6364831135868332
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23526,171,0.98 [0.69-1.38],0.893907725779381
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23851,83,0.62 [0.36-1.08],0.0928838163318482
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23690,460,1.04 [0.85-1.28],0.6886459936059338
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23496,129,0.91 [0.61-1.35],0.632986786396833
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22625,1805,1.07 [0.96-1.19],0.2147594838997255
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23846,199,1.12 [0.82-1.53],0.4593880876214052
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23991,146,1.35 [0.97-1.88],0.0766761399520555
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23500,419,0.99 [0.80-1.24],0.9589773211158126
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23712,65,1.88 [1.22-2.89],0.0040791282370469
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23993,55,1.28 [0.73-2.25],0.3804799513030925
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23159,78,1.42 [0.90-2.22],0.1321697384300833
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23222,141,0.95 [0.65-1.38],0.7779607575553453
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22880,128,1.12 [0.76-1.64],0.5720618533889686
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23406,51,1.25 [0.70-2.23],0.4545087719391103
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22817,65,0.87 [0.48-1.55],0.6316778741586352
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23283,53,1.75 [1.07-2.86],0.0252395512029975
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23440,210,1.20 [0.90-1.61],0.2150283272838703
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23199,118,1.29 [0.89-1.87],0.172020946408366
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22874,122,0.74 [0.48-1.15],0.1842553217426806
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22847,95,1.60 [1.09-2.35],0.0166207220633958
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22300,1480,1.20 [1.08-1.34],0.0008513609405699
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23139,58,1.00 [0.56-1.79],0.9981458963072194
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23758,391,0.96 [0.76-1.20],0.7061890425733557
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23437,70,1.23 [0.74-2.03],0.4282472878249488
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23536,169,1.12 [0.80-1.55],0.5130072443358973
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23828,57,1.30 [0.75-2.23],0.3520576744131779
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23965,121,0.99 [0.66-1.49],0.9535463838512862
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23872,113,1.74 [1.25-2.44],0.0011977767787995
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23821,50,1.18 [0.65-2.14],0.5804755034055357
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23825,54,0.85 [0.45-1.60],0.6131604021360502
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23913,979,1.03 [0.89-1.18],0.7312008571963708
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23661,727,1.03 [0.87-1.21],0.7336553896471825
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23065,131,0.77 [0.51-1.17],0.2235453628800386
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23020,86,1.57 [1.05-2.36],0.0296673349356987
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23793,63,1.63 [1.02-2.60],0.0402726243457632
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23921,191,1.27 [0.94-1.70],0.1182063791958242
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23792,62,0.97 [0.55-1.71],0.9099843700375502
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza,21702,108,1.50 [1.03-2.18],0.0348160562518129
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21699,105,1.51 [1.03-2.21],0.0336305950420069
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15744,107,1.28 [0.85-1.93],0.233498627957179
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23898,267,1.04 [0.79-1.36],0.8050166287126105
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16737,1451,1.26 [1.12-1.40],5.8306443740629975e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17061,1424,1.25 [1.11-1.39],0.0001142622270099
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23617,151,1.62 [1.19-2.20],0.0022057899622561
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21690,96,1.54 [1.04-2.29],0.0324147475939878
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,20868,289,1.42 [1.13-1.80],0.0031020149850398
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20623,44,1.30 [0.70-2.42],0.4098109727651988
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23151,2572,1.20 [1.10-1.30],2.2243851746596203e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22554,80,0.99 [0.60-1.64],0.97526559221595
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22637,163,1.25 [0.90-1.73],0.1788984764284192
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23782,1307,1.37 [1.22-1.53],3.9697766145303057e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22615,141,0.79 [0.53-1.18],0.2492054076669384
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21983,5316,1.20 [1.13-1.27],2.574518236843653e-09
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22866,392,1.00 [0.80-1.25],0.9821346299928456
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,22784,309,1.49 [1.20-1.86],0.0003290078089415
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Emphysema,20930,351,1.36 [1.09-1.69],0.0062697829033961
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23069,342,1.32 [1.06-1.64],0.0126389095479685
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23757,2163,1.37 [1.25-1.49],1.323404856693617e-12
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,23097,370,1.39 [1.13-1.71],0.001822486120081
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Later onset COPD,22930,998,1.35 [1.19-1.54],6.699426360605382e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23989,430,1.10 [0.89-1.35],0.3920297753388196
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22621,147,1.32 [0.95-1.85],0.0969181564699204
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23735,1011,1.31 [1.15-1.49],3.909634565761131e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23724,2208,1.43 [1.31-1.55],8.629682461363508e-17
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23347,873,1.02 [0.88-1.19],0.7547615562187105
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,21580,64,1.77 [1.14-2.75],0.0109729808717528
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23911,454,1.56 [1.31-1.86],9.621623607834516e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23883,1396,1.39 [1.25-1.55],1.3602175419965502e-09
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,22646,1130,1.67 [1.50-1.87],2.793035016429045e-20
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural plaque,21781,265,1.43 [1.12-1.83],0.00439249042335
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23491,1897,1.40 [1.28-1.54],4.007205209640548e-13
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23888,329,1.23 [0.97-1.55],0.0863366833994738
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumothorax,21658,142,1.60 [1.17-2.19],0.0030825449716601
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pollen allergy,23991,232,1.04 [0.77-1.40],0.8051052469068503
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23525,68,2.41 [1.67-3.50],3.328864220686508e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15693,56,1.27 [0.72-2.25],0.4023965491333323
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23717,993,1.31 [1.15-1.49],3.54918207503384e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22743,269,1.04 [0.79-1.37],0.7718483024673524
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,21878,284,1.04 [0.80-1.36],0.7468999017413929
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23635,241,1.01 [0.76-1.35],0.9455776283224984
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10463,115,1.60 [1.09-2.36],0.016143746864019
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16763,89,0.83 [0.51-1.37],0.471213682412945
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23871,146,0.72 [0.48-1.07],0.1038026535280283
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute gastritis,18117,91,1.48 [0.98-2.25],0.0629651199368752
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22643,203,1.16 [0.87-1.57],0.3125889304226128
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,23642,101,2.75 [2.10-3.60],1.3562994739125725e-13
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23104,116,4.44 [3.63-5.44],2.250982564754248e-47
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18560,534,1.15 [0.96-1.39],0.1382867498617107
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22562,122,1.14 [0.77-1.68],0.5239327307079444
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23599,122,1.13 [0.76-1.66],0.552425476706082
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,22659,219,0.72 [0.52-0.99],0.0463604790497986
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,23230,790,1.02 [0.87-1.19],0.8064737034827049
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,18293,267,1.37 [1.06-1.75],0.0143071455907519
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22498,58,1.61 [0.99-2.63],0.0569416065611935
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23799,136,4.60 [3.84-5.50],9.275197852949328e-63
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,22363,93,0.67 [0.40-1.13],0.1323451423129932
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,22560,50,1.62 [0.95-2.74],0.074603349087859
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23841,221,0.96 [0.71-1.30],0.7902906826953648
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,23842,1607,1.20 [1.08-1.33],0.0006420001762818
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,22603,93,1.56 [1.05-2.31],0.0270931610552862
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23663,67,1.33 [0.81-2.18],0.2521120607113872
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22588,78,1.77 [1.18-2.65],0.0057314362394375
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,23357,227,1.33 [1.01-1.74],0.0405511376949918
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20324,1957,1.04 [0.94-1.15],0.4559941614399704
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23903,178,0.66 [0.46-0.96],0.0281193262458601
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,23865,877,2.32 [2.09-2.58],1.5362629217014618e-54
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21993,3967,1.16 [1.09-1.25],1.3201576657020162e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23645,515,1.36 [1.14-1.63],0.0005720094467468
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23957,416,1.32 [1.08-1.61],0.0058196916481974
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23241,111,1.18 [0.79-1.77],0.4082849535730251
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23097,67,1.11 [0.65-1.90],0.7011431636372079
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23688,1418,1.33 [1.19-1.48],2.692456844584265e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,23117,110,1.45 [0.99-2.11],0.0534834734883863
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23633,1193,1.11 [0.98-1.26],0.0995005876036499
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19742,3068,1.02 [0.94-1.11],0.5841400913613648
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,18295,269,1.58 [1.25-1.99],0.0001319965112262
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23890,211,1.44 [1.10-1.89],0.0072374094240128
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23932,47,0.76 [0.38-1.54],0.4523372385443336
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23147,159,4.30 [3.62-5.10],1.2137997534512188e-62
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16855,181,1.00 [0.72-1.40],0.9950854882997506
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18455,429,1.07 [0.87-1.33],0.517180410063796
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,18395,369,1.43 [1.16-1.76],0.0008393410299187
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20205,2179,0.99 [0.90-1.09],0.8130303820764484
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18628,602,1.46 [1.24-1.72],4.040892603924931e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18358,8048,1.05 [1.00-1.11],0.0464401746895025
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,23449,1179,1.37 [1.22-1.54],1.6398364072029941e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23176,46,1.53 [0.86-2.69],0.1448922375584817
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17646,1245,1.03 [0.91-1.17],0.6135513873737926
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23076,88,4.07 [3.22-5.14],1.080827216921387e-31
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,21935,3568,0.99 [0.92-1.07],0.8850594134505407
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23935,44,0.72 [0.35-1.51],0.3853066929692024
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,16721,47,1.49 [0.85-2.60],0.1600336713010566
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,20017,1650,0.94 [0.84-1.05],0.277263489674701
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18567,200,1.14 [0.84-1.55],0.3889992588872919
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16765,91,1.47 [0.98-2.19],0.0631022581265423
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22376,106,0.76 [0.47-1.21],0.2512058676518562
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16946,272,1.13 [0.87-1.47],0.3575665668635576
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23965,380,1.96 [1.65-2.33],2.1956997220030737e-14
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23192,682,1.22 [1.04-1.43],0.0132474338224855
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23404,894,1.22 [1.06-1.40],0.0060272311197661
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18242,216,1.25 [0.94-1.66],0.1256385408325035
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,18661,635,1.38 [1.18-1.62],7.389753449119725e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23954,115,0.95 [0.62-1.45],0.816255669069897
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18446,79,1.27 [0.80-2.02],0.3102039829513084
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18117,1443,1.03 [0.92-1.16],0.5785231175020333
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22699,259,1.04 [0.79-1.37],0.7690954191039288
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22564,124,0.87 [0.57-1.32],0.5060537774304728
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18565,1891,1.15 [1.04-1.26],0.0064668622500961
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22180,5506,1.07 [1.01-1.13],0.0309454395754542
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23080,181,0.88 [0.62-1.24],0.4654469563434628
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,23688,700,2.35 [2.09-2.65],6.263189307911311e-46
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18772,746,1.27 [1.09-1.48],0.002507336707152
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22583,143,1.53 [1.11-2.10],0.0099440548415281
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23883,342,0.98 [0.77-1.25],0.8738670601577454
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18835,809,1.48 [1.29-1.70],2.321656083101781e-08
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23461,1191,1.37 [1.22-1.54],1.131915457982421e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23310,180,1.25 [0.91-1.70],0.1660424242005689
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18319,1645,1.21 [1.09-1.35],0.000258819784732
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19909,1883,1.30 [1.18-1.43],9.146121195298905e-08
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23087,99,3.11 [2.40-4.02],1.0478895534051121e-17
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23292,782,1.25 [1.08-1.45],0.0032645593895083
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17028,354,1.28 [1.03-1.59],0.0234828806384745
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23923,56,0.79 [0.41-1.49],0.462293922726125
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17154,480,1.32 [1.10-1.59],0.0030524892638158
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22436,166,1.55 [1.16-2.08],0.0034640151270721
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23993,44,1.05 [0.55-2.04],0.876934627415151
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23139,108,1.10 [0.72-1.68],0.6550486789260213
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Toxic colitis,22557,47,0.94 [0.49-1.84],0.865590858369615
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18324,298,1.19 [0.93-1.52],0.1776551100276627
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22660,150,0.95 [0.66-1.38],0.7996609940664163
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22636,126,0.97 [0.64-1.45],0.867716810300291
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,18741,374,1.00 [0.80-1.26],0.9687804067618884
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16833,159,1.29 [0.93-1.78],0.1215107705481197
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,18634,267,1.08 [0.83-1.40],0.5727233761386703
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Volvulus,16747,73,1.46 [0.93-2.29],0.100145410576113
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23930,332,1.13 [0.90-1.44],0.2946107045292561
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23684,69,1.20 [0.73-1.97],0.4734476490974197
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21994,98,1.01 [0.64-1.59],0.963213399879651
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23266,767,1.58 [1.38-1.81],2.2190355736306907e-11
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22702,203,1.11 [0.82-1.51],0.5034761656428347
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22369,473,1.73 [1.46-2.05],2.0082580530836807e-10
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23710,269,1.09 [0.83-1.42],0.5303781617068573
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23917,476,1.11 [0.91-1.36],0.2877455726864661
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23486,45,1.54 [0.88-2.70],0.1329884202968104
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22510,3211,1.29 [1.20-1.39],2.672747154487948e-12
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23555,410,1.02 [0.82-1.27],0.8576650731979474
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23441,296,1.00 [0.77-1.30],0.9983600813718438
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23544,1045,1.48 [1.31-1.66],1.4379962400341628e-10
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23997,31,1.65 [0.86-3.15],0.1287165202398241
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21919,23,0.40 [0.14-1.18],0.0974935211346835
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23203,58,0.99 [0.56-1.76],0.9700207212072004
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23705,264,1.11 [0.85-1.45],0.4411119880846951
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22382,486,1.20 [0.99-1.46],0.0620086935061562
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21976,80,1.11 [0.68-1.81],0.685182936536072
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23940,83,1.32 [0.84-2.05],0.2273299882861003
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22718,219,1.72 [1.34-2.19],1.6697281122475816e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23835,220,1.06 [0.79-1.42],0.6933669303396628
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23513,72,1.22 [0.74-2.01],0.4329500157062498
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21964,68,1.20 [0.71-2.01],0.4988748488647625
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23546,1650,1.44 [1.30-1.58],2.0893799776488485e-13
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22423,527,1.25 [1.04-1.50],0.0165050093596635
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21979,83,1.13 [0.70-1.82],0.6236383477153228
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23916,301,1.02 [0.80-1.32],0.8498328006975295
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23495,54,0.72 [0.38-1.38],0.3277398642579371
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23879,264,0.98 [0.74-1.28],0.8599633616413376
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23950,352,1.11 [0.88-1.40],0.3696793801292882
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21987,91,1.04 [0.65-1.66],0.8606767984041825
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22169,273,1.12 [0.86-1.46],0.4088582822309806
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23943,345,1.12 [0.89-1.41],0.3335701279786687
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22167,271,2.23 [1.84-2.70],4.3314964216107796e-16
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23982,125,1.47 [1.04-2.07],0.0293945231833622
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20730,92,1.39 [0.93-2.08],0.1125555260646966
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21908,4817,1.11 [1.04-1.18],0.0017454643304391
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20488,3397,1.07 [1.00-1.16],0.0666639225482534
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20708,70,0.69 [0.38-1.24],0.2152067012262997
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21080,153,1.30 [0.93-1.82],0.1254353132965841
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21071,144,1.04 [0.72-1.51],0.8232707657678464
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23803,68,0.90 [0.52-1.58],0.7252779397361551
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21007,80,1.32 [0.83-2.12],0.2433790008122557
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17969,878,1.04 [0.90-1.21],0.5950651752337344
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23889,152,0.83 [0.57-1.21],0.3363922407081301
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21201,274,1.12 [0.86-1.45],0.4066212146820201
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20433,6310,1.07 [1.01-1.13],0.0172507855039306
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22937,92,1.24 [0.80-1.91],0.3424773466072808
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20805,167,1.10 [0.78-1.54],0.5938782550791714
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21076,438,1.03 [0.83-1.27],0.8100144726586043
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23178,2251,1.16 [1.06-1.27],0.0010120827260598
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21004,366,0.97 [0.77-1.23],0.80624235993414
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20691,53,0.71 [0.36-1.38],0.3076345804714387
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20732,94,1.00 [0.63-1.60],0.9909604513943472
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23690,31,0.89 [0.39-2.03],0.7786486258502903
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18569,1478,1.07 [0.96-1.20],0.2227293501555369
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18085,994,1.40 [1.24-1.58],1.231191000183588e-07
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23867,980,1.37 [1.21-1.56],7.263983188880291e-07
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,17140,49,1.40 [0.80-2.47],0.2394148326702771
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17170,79,1.56 [1.01-2.40],0.0457338053964395
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20912,274,0.87 [0.66-1.15],0.3234229517198661
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17726,635,0.92 [0.76-1.11],0.3760334974870484
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20970,43,1.78 [1.02-3.13],0.0437963766175984
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21459,532,1.14 [0.94-1.37],0.1799743516946569
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21197,270,1.25 [0.97-1.62],0.0785466216573663
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17685,594,0.89 [0.73-1.08],0.2217286679401822
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20704,66,1.50 [0.93-2.41],0.0929676655368107
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20692,54,0.57 [0.29-1.14],0.1134908486875464
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22939,94,2.08 [1.48-2.92],2.6200680898869497e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23715,870,1.27 [1.10-1.46],0.0008512172004513
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23252,407,1.51 [1.25-1.83],2.2417298665672067e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23923,288,1.27 [1.00-1.62],0.0496310907384453
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18987,1896,1.14 [1.04-1.26],0.0072911960362658
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17141,50,0.96 [0.50-1.83],0.8957528434511031
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20721,83,0.92 [0.55-1.52],0.7432241468656666
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17146,55,1.32 [0.76-2.27],0.3220876664679468
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),17136,45,1.54 [0.87-2.75],0.1389314066262283
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23031,186,0.86 [0.61-1.21],0.3749168172776387
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23009,164,0.98 [0.68-1.39],0.8915542183732023
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23972,87,0.80 [0.48-1.34],0.4006209004327331
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22463,1536,1.14 [1.02-1.27],0.0180107058885954
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20705,67,1.01 [0.58-1.76],0.9601341003878168
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17132,41,1.38 [0.74-2.55],0.3080128239717303
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21547,620,1.20 [1.02-1.43],0.0324494168098324
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18815,1724,1.11 [1.00-1.23],0.0505950932903228
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23715,56,0.92 [0.50-1.69],0.7831074952857605
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23989,63,1.26 [0.76-2.10],0.3709986296638028
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20720,82,0.90 [0.54-1.49],0.6809367508606698
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21630,992,1.21 [1.06-1.38],0.0047114662697141
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20734,96,1.46 [0.98-2.17],0.0604229988134538
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18309,1218,1.11 [0.98-1.26],0.104924385169331
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22931,86,0.55 [0.32-0.94],0.0299542150908534
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20682,44,0.68 [0.32-1.45],0.3183274002753721
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21040,113,1.00 [0.66-1.52],0.9826942123401924
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21144,506,1.20 [1.00-1.45],0.0548512269333169
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23852,193,1.01 [0.73-1.39],0.9573390856942592
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21412,485,1.08 [0.88-1.32],0.454153983026179
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23932,282,1.25 [0.98-1.59],0.0772120416578027
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23992,39,1.01 [0.49-2.06],0.9872295327830808
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20791,153,1.08 [0.76-1.53],0.6732117705550562
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19687,578,1.30 [1.10-1.55],0.0023781929556117
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21125,487,1.19 [0.99-1.44],0.0692957332325038
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20969,331,0.93 [0.72-1.20],0.5912338223111878
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",17122,31,0.98 [0.44-2.19],0.96207196217016
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19381,2290,1.20 [1.10-1.31],3.503190625750439e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17545,454,1.13 [0.93-1.39],0.2212129907928478
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23823,164,1.10 [0.79-1.54],0.5826831128319697
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23933,48,0.92 [0.48-1.79],0.815534517769872
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22001,46,1.11 [0.61-2.03],0.7354813998792149
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17156,65,1.30 [0.78-2.16],0.3136915386907128
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21016,89,1.04 [0.65-1.66],0.876408424018217
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17387,296,1.30 [1.02-1.65],0.0314605723424013
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20916,278,0.83 [0.63-1.10],0.2040148880293221
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21147,220,1.05 [0.78-1.42],0.7492354412294165
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21020,93,1.31 [0.85-2.01],0.2249662394046062
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,19055,31,1.38 [0.68-2.83],0.3732100592663168
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23993,40,0.83 [0.39-1.74],0.6158467952722843
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21170,532,0.94 [0.78-1.15],0.5654361339118064
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23678,19,0.90 [0.62-1.31],0.5752489652716402
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22924,2286,1.09 [1.00-1.20],0.0521986257813237
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20745,107,0.98 [0.64-1.51],0.9319705263205542
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21437,510,1.28 [1.07-1.53],0.0082743984229901
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22939,200,1.08 [0.80-1.47],0.6000938174531976
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21058,131,0.96 [0.65-1.42],0.8363578212460481
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22253,1326,1.22 [1.08-1.36],0.0009021786872867
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21755,828,1.16 [1.00-1.35],0.0483465209617047
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20681,43,1.26 [0.67-2.37],0.4703681930210039
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23697,38,0.97 [0.47-2.01],0.937246662450105
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20759,121,1.08 [0.73-1.59],0.7121719334917301
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20661,23,0.80 [0.30-2.08],0.6405506380029096
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17151,60,1.24 [0.72-2.15],0.4373327256442481
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22997,1883,1.66 [1.53-1.81],5.285054658342942e-32
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23525,413,1.05 [0.85-1.31],0.6489739393416605
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23252,140,0.84 [0.57-1.25],0.3963103634868782
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22666,1552,1.65 [1.50-1.82],1.5251981117169351e-25
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23752,86,2.21 [1.60-3.06],1.627771477329853e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23724,360,1.06 [0.84-1.33],0.6387852334138755
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,21107,212,1.01 [0.74-1.37],0.9466108713219236
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,21220,106,1.90 [1.35-2.66],0.0002044133977534
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22714,3350,1.05 [0.97-1.13],0.2007690404468813
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21612,5624,1.19 [1.13-1.26],6.812612611227851e-10
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23770,104,2.26 [1.66-3.08],2.3298950278317785e-07
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19574,210,1.16 [0.87-1.56],0.3170504960293662
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21220,374,1.09 [0.87-1.37],0.4383407589821243
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,22000,2636,1.06 [0.97-1.15],0.1816959163669551
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19598,234,1.08 [0.82-1.44],0.5821748839931589
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20975,80,0.99 [0.60-1.62],0.9563615180883804
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19475,111,1.02 [0.67-1.55],0.9377179140627098
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23995,61,1.15 [0.67-1.99],0.6076836710524551
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24000,57,0.75 [0.40-1.43],0.3874307169240532
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23168,2273,1.16 [1.06-1.26],0.0015518024890422
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21854,959,1.04 [0.90-1.20],0.5874938879020053
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23931,567,1.04 [0.86-1.25],0.7147030564287857
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19677,313,1.20 [0.95-1.52],0.1315429200670929
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19645,281,1.03 [0.79-1.34],0.8347865352186546
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19597,233,0.78 [0.57-1.06],0.1160262873622182
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23990,49,0.85 [0.44-1.64],0.6206082400117989
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22442,1547,1.22 [1.09-1.35],0.0003173621723447
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21266,420,1.10 [0.89-1.36],0.3925108181997901
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23555,191,0.98 [0.71-1.35],0.886075945956035
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23725,59,1.35 [0.80-2.28],0.2634081829261255
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19634,270,1.03 [0.79-1.34],0.8224782256525185
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23702,2856,1.47 [1.37-1.59],1.258514121027692e-25
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20921,75,1.33 [0.83-2.14],0.23575698553419
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21273,159,2.16 [1.68-2.78],2.156926384679184e-09
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23190,78,0.61 [0.35-1.07],0.0876370345706108
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21194,299,1.15 [0.89-1.47],0.2805680416941416
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23642,530,0.99 [0.81-1.20],0.9005984673053311
